News and Trends 19 Dec 2025 U.S. vaccine approvals to undergo overhaul: what do the changes mean? A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts warn. December 19, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Oct 2025 Six companies leading the mRNA revolution in biotechnology Here are six mRNA biotechs that have raised funds in recent years to push their candidates ahead through preclinical and clinical trials. October 7, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 18 Aug 2025 mRNA vaccine funding cuts: the impact on U.S. healthcare and biotech The U.S. government announced funding cuts to mRNA vaccine research. What is the impact on American healthcare and biotech? August 18, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 2 May 2025 From pandemic spotlight to post-COVID crossroads: What happened to these biotech players? Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article. May 2, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 23 Jan 2025 mRNA, RNAi, circRNA, ASOs: A comparative guide to RNA therapeutics In this review of RNA therapies, we paint an overview of what’s going on in a field that could address a number of diseases. January 23, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Oct 2024 Six biomimicry biotech companies harnessing nature’s wisdom to develop breakthrough drug candidates Find out more about six biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human health. October 14, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 1 Aug 2024 CureVac: From a failed drug to a €1.45 billion deal In 2021, CureVac’s COVID-19 candidate came short. Discover how the company leveraged its deal with GSK to restructure and turn things around. August 1, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 4 Apr 2024 Seven diseases CRISPR technology could cure Here are some of the diseases that scientists aim to tackle using CRISPR technology, testing its possibilities and limits as a medical tool. April 4, 2024 - 11 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 26 Jan 2024 Long COVID: are we on the verge of a breakthrough? Studies and recent developments in long COVID research could pave the way for more diagnostic and therapeutic opportunities. January 26, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 15 Dec 2023Vaxxinity making vaccines to change the world Discover how Vaxxinity’s vaccine approach aims to democratize global health, potentially reshaping access to innovative treatments worldwide. December 15, 2023 Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Nov 2023 Eight biotech companies tackling infectious diseases head-on Infectious diseases are diseases that are caused by pathogens that enter the body, hijack the body’s immune system and multiply, causing an infection. Five of the deadliest infectious diseases are measles, tuberculosis, malaria, diarrhoeal disease and influenza, according to the World Economic Forum. While Our World in Data statistics suggest that there has been almost […] November 7, 2023 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 20 Oct 2023 Is Africa ready to become the next big biopharma and vaccine manufacturing destination? Localizing pharma manufacturing worldwide is an extremely important step, and it holds particular significance for Africa. The continent is more vulnerable to disease burdens and lags behind other continents when it comes to vaccine and general healthcare access. Localized manufacturing could help people in Africa gain easier and more affordable access to vaccines and other […] October 20, 2023 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email